Compare AROW & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AROW | EMBC |
|---|---|---|
| Founded | 1851 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 547.8M | 602.3M |
| IPO Year | 1995 | 2021 |
| Metric | AROW | EMBC |
|---|---|---|
| Price | $32.19 | $9.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $28.00 | $18.50 |
| AVG Volume (30 Days) | 78.1K | ★ 868.8K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | 3.59% | ★ 6.62% |
| EPS Growth | ★ 49.72 | 20.90 |
| EPS | ★ 2.65 | 0.74 |
| Revenue | N/A | N/A |
| Revenue This Year | $17.58 | $1.17 |
| Revenue Next Year | $5.21 | N/A |
| P/E Ratio | $18.46 | ★ $12.30 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.72 | $9.06 |
| 52 Week High | $36.44 | $15.55 |
| Indicator | AROW | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 38.27 | 28.75 |
| Support Level | $31.33 | N/A |
| Resistance Level | $33.30 | $10.88 |
| Average True Range (ATR) | 1.00 | 0.34 |
| MACD | -0.27 | -0.08 |
| Stochastic Oscillator | 6.80 | 13.59 |
Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of company's revenue is interest income, fees, commission earned through its subsidiaries.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.